Oxymatrine is a traditional Chinese herbal product that exhibits anti-inflammatory effects in models of heart, brain and liver injury. We investigated the impact of oxymatrine in an acute model of intestinal injury and inflammation. Oxymatrine significantly decreased LPS-induced NF-kB-driven luciferase activity, correlating with diminished induction of Cxcl2, Tnfa and Il6 mRNA expression in rat IEC-6 and murine BMDC. Although oxymatrine decreased LPS-induced p65 nuclear translocation and binding to the Cxcl2 gene promoter, this effect was independent of IkBa degradation/phosphorylation. DSS-induced weight loss and histological damage were ameliorated in oxymatrine-treated C57BL/6-WT-mice. While this effect correlated with reduced colonic Il6 and Il1b mRNA accumulation, global NF-kB activity as measured in NF-kB EGFP mice was unaffected. Our data demonstrate that oxymatrine reduces LPS-induced NF-kB nuclear translocation and activity independently of IkBa status, prevents intestinal inflammation through blockade of inflammatory signaling and ameliorates overall intestinal inflammation in vivo.
H erbal products and traditional medicines are estimated to be the primary means of healthcare for up to 80% of the population in some Asian and African countries, with herbal treatments being the most popular 1 . Popularity for use of herbal products as complementary medication in western countries has risen dramatically in recent years, and in the United States the use of herbal products is estimated at between 20-38% among adults 2-4 while in some European countries this estimate rises to a range of 50-70% 5 . However, the lack of tight regulation of herbal products (production, purity and quality), unsustainable health claims and the lack of defined mechanisms of action prevents the incorporation of many herbal treatments into mainstream medicine 2 . Oxymatrine, classified as a quinolizidine alkaloid, is an herbal product derived from the root of the Sophora flavescens Ait. plant 6 . Oxymatrine has been primarily used in China for the treatment of various human illnesses such as hepatitis B infections and liver fibrosis 7, 8 . It has also been reported to provide a protective effect in various animal models of ischemia and reperfusion (I/R)-induced liver, heart, and intestinal injury [9] [10] [11] . The molecular pathways by which oxymatrine mediates its protective effects remain unclear but appear to involve both inhibition of p38MAPK phosphorylation 11, 12 , and decreased NF-kB subunit p65 protein expression 13, 14 . In addition to the aforementioned protection from I/R-induced injury, it was reported that oxymatrine administration decreased dextran sulfate sodium (DSS) induced colitis in rats 15 , although the mechanism of action was not fully investigated. Here we show that oxymatrine prevents LPS induced pro-inflammatory gene expression in bone marrowderived dendritic cells (BMDC) and in intestinal epithelial cells (IEC). We demonstrate that oxymatrine dampens NF-kB activity by inhibiting LPS-induced nuclear translocation of p65, an effect independent of signal induced IkB phosphorylation/degradation. Importantly, oxymatrine ameliorates DSS-induced weight loss, histopathological scores and expression of Il1b and Il6 pro-inflammatory gene expression without global inhibition of NFkB transcriptional activity.
(IEC)-6 line with LPS and treated cells using various concentrations of oxymatrine and measured expression of pro-inflammatory mediators. LPS-induced Cxcl2, Tnfa and Il6 mRNA expression were significantly reduced in presence of oxymatrine (p , 0.05) at 1 hr but only Cxcl2 remained inhibited by 4 hr (Fig. 1) . LPS-induced //1b mRNA accumulation was unaffected by oxymatrine treatment (Fig. 1) . To ensure that cell death was not responsible for the decreased LPS-induced cytokine expression by oxymatrine, we performed a cell viability assay. No significant difference in cell mortality was noticed in cells treated with oxymatrine or co-treated with oxymatrine and LPS compared to control cells (, 5% at 4 mg/ml) (data not shown).
In order to assess the effect of oxymatrine on immune cell activity, we generated BMDCs from WT mice. Analysis of the kinetics of LPSinduced Il6 and Tnf mRNA accumulation in treated BMDCs showed that oxymatrine significantly inhibited Il6 at 1 and 4 hr (p , 0.01) and Tnfa at 4 hr of stimulation (p , 0.01), while Il1b expression was unaffected (Fig. 2) . These findings indicate that oxymatrine prevents expression in a selective group of LPS-induced pro-inflammatory genes in both IEC and immune cells.
Oxymatrine prevents NF-kB activity without blocking IkBa phosphorylation and through inhibition of p65 nuclear translocation. Since LPS-induced Cxcl2 is dependent on NF-kB activity 16 , we investigated the impact of oxymatrine on this pathway. Using an NF-kB luciferase reporter assay we were able to show that oxymatrine significantly inhibited LPS-induced NF-kB transcriptional activity in a dose-dependent manner compared to control LPS stimulated cells (p , 0.01) (Fig. 3a) . To identify the target of oxymatrine mediated NFkB blockade, we investigated the status of IkBa phosphorylation/ degradation. As expected, we observed a time-dependent increase in LPS-induced IkBa phosphorylation with concomitant degradation of total IkBa (Fig. 3b) . Interestingly, oxymatrine failed to prevent LPSinduced IkBa phosphorylation/degradation (Fig. 3b) . Reduced IkBa levels in LPS-stimulated, oxymatrine-treated cells at 90 min likely reflects the canonical nature of NF-kB signaling where blockade of the transcription factor leads to decreased expression of its inhibitor. In contrast, oxymatrine significantly reduced (p , 0.05) LPS-induced p38MAPK phosphorylation in IECs at 60 min (Fig. 3c) .
Because NF-kB transcriptional activity was blocked independently of IkBa phosphorylation/degradation by oxymatrine treatment, we investigated the subcellular compartmentalization of the NF-kB transcriptional subunit p65. IEC-6 cells were treated with oxymatrine and stimulated with LPS for 0-60 min and p65 localization determined by immunofluorescent microscopy. Pre-treatment with oxymatrine followed by LPS stimulation resulted in a statistically significant reduction in LPS-induced p65 nuclear accumulation compared to LPS-only treated cells (,40%; p , 0.01) (Fig. 4a-b) . Although higher oxymatrine concentration (8 mg/mL) resulted in an increased inhibition (,70%) of nuclear translocation (Supplementary Fig. S1 ), this dosage was associated with cellular toxicity (data not shown). To confirm that oxymatrine prevents LPS-induced NF-kB binding to the Cxcl2 promoter, we performed p65 chromatin immunoprecipitation using IEC-18 cells. LPS stimulation resulted in increased p65 binding to the Cxcl2 gene promoter at 30 min, which then decreased by 60 min, a process inhibited by oxymatrine treatment (Fig. 4c) .
Oxymatrine ameliorates DSS-induced colitis. To determine the potential in vivo anti-inflammatory therapeutic effect of oxymatrine, we tested this herbal product using the DSS model of acute intestinal inflammation. DSS-induced weight-loss was approximately 15% in control mice, whereas mice treated with low (50 mg/kg) or high (200 mg/kg) doses of oxymatrine were significantly protected from weight-loss by d 9 ( Fig. 5a ; p , 0.05). Oxymatrine-injected control groups displayed no significant change in body weight (Fig. 5a ). Histological analysis revealed a significantly lower DSS injury score (p , 0.05) with either low-or high-dose oxymatrine treatment ( Fig. 5b-c) . We examined the levels of colonic inflammatory mediators in the different groups using realtime PCR and found a significant increase (p , 0.05) of colonic Il6, Il1b and Tnfa mRNA accumulation in DSS-exposed mice (Fig. 5d) . Interestingly, DSS-induced Il6 and IL1b mRNA accumulation were dose-dependently inhibited in oxymatrine-treated mice (Fig. 5d) . However, oxymatrine failed to inhibit DSS-induced TNF mRNA accumulation in vivo (Fig. 5d) . In addition, expression of the proliferative marker Ki-67 within intact colonic crypts decreased in DSS-exposed, oxymatrine-treated mice compared to untreated mice, suggesting an improved intestinal response (Fig. 5e , Supplementary  Fig. S2 ). To gain more insight into in vivo NF-kB activation, we utilized NF-kB EGFP reporter mice 17 . We observed increased EGFP expression in DSS-exposed NF-kB EGFP mice compared to untreated mice (Fig. 5f ). NF-kB EGFP mice exposed to DSS and treated with 200 mg/Kg oxymatrine showed similar pattern of EGFP expression to DSS-exposed mice (Fig. 5f ), and these expression levels were confirmed using western blot analysis ( Supplementary  Fig. S2 ). These findings showed that oxymatrine reduced DSSinduced acute colitis, which correlates with attenuation of a selective set of pro-inflammatory cytokine gene expression, without globally preventing NF-kB activation.
Discussion
The increasing interest in alternative medicine worldwide, especially naturally derived herbs and plant extracts, has spurned research into elucidating mechanism of action attributed to these compounds. Oxymatrine has shown promising beneficial effects in rodent models of I/R-induced liver, heart and lung injury [9] [10] [11] . In this study, we show that oxymatrine administration is able to significantly inhibit LPSinduced pro-inflammatory cytokine production in both immune and non-immune cells. We demonstrate that this inhibitory effect is associated with decreased NF-kB p65 nuclear migration. Finally, we validated the therapeutic potential of oxymatrine in vivo by showing that DSS-induced acute injury and colitis was attenuated by both low and high doses of the natural product. It is important to note that the intestinal epithelial cell layer is severely damaged upon DSS exposure, which causes a massive influx of bacteria and bacterial products (including LPS) into the normally segregated mucosal immune system. Therefore, the use of LPS in vitro is a means to reproduce the secondary effect of DSS in vivo (exposure of IEC and immune cells to bacterial products). This standard model of LPS stimulation in vitro to simulate and measure inflammatory responses, and the use of DSS-induced injury and colitis in vivo has been used in numerous reports [18] [19] [20] [21] [22] [23] including studies published from our group 24, 25 .
An intriguing aspect of our study is that oxymatrine failed to inhibit LPS-induced IkBa phosphorylation/degradation, while blocking p65 nuclear translocation. This suggests that oxymatrine mediates its effect downstream of the classical IKK/IkB induced NFkB activation. However, the p65 subunit contains a nuclear localization domain that is recognized by the karyopherin chaperone protein importin3a and interference between this chaperone protein and target p65 can impact nuclear shuttling 26 . Although we observed decreased p65/Importin a3 binding at steady state levels in the presence of oxymatrine, attempts to show increased interaction between the chaperone and p65 following LPS stimulation were unsuccessful (data not shown). Regardless of the exact mechanism of action, our study clearly demonstrates an inhibitory effect of oxymatrine on signal-induced p65 nuclear translocation at the level of protein localization (immunofluorescence) and DNA binding (ChIP assay). Previous studies by Fan H et al. showed that oxymatrine acts by reducing p65 protein expression in a rat model of TNBSinduced colitis 14 , and a recent report shows that matrine, the related herbal product derived from the same plant, inhibits NF-kB in neurons and astrocytes in an IkB-dependent manner 27 . However, as we failed to observe either decreased p65 expression in oxymatrinetreated cells or inhibition of IkB-phosphorylation, we conclude that oxymatrine's main mechanism of action is sequestration of p65 in the cytoplasm, at least in IECs and BMDCs.
Oxymatrine shows no apparent global inhibitory effect on NF-kB transcriptional activity in vivo as seen in oxymatrine-treated, DSSexposed NF-kB EGFP mice. This is an important observation since NFkB transcriptional activity is necessary to maintain epithelial barrier function and proper response to wound healing [28] [29] [30] [31] . Though we see no global inhibition of NF-kB activity, mice treated with DSS and oxymatrine showed lower numbers of Ki-67 1 cells within intact colonic crypts compared to untreated mice and far less than DSS treated mice. This difference may be indicative of the selective ability of oxymatrine to alter gene expression as we also observed a significant decrease in Il6 and Il1b mRNA levels but sustained levels of Tnfa mRNA in vivo. Interestingly, TNFa exerts a protective function in DSS-induced colitis 32, 33 and this may explain the beneficial impact of oxymatrine in vivo. Though oxymatrine blocks LPS-induced TNFa production in both IECs and BMDCs in vitro, the in vivo source of TNFa is not clear. Intestinal myofibroblasts 34 and NKT 35 cells are an important source of TNFa and could be unaffected by oxymatrine exposure. In addition, it is possible that the effect of oxymatrine on NF-kB in vivo could be coupled with effects on other signaling pathways such as p38MAPK 11, 12 and acts to balance target gene transactivation lowering pro-inflammatory effects while preserving cyto-protective ones. A more comprehensive analysis (RNA-seq, gene array) would help understand the impact of oxymatrinemediated transcriptional inhibition.
Although oxymatrine demonstrates a beneficial effect in the DSSmodel of acute intestinal injury, it should be noted that not all herbal products ameliorate colitis. We recently showed that while another herbal product tomato lycopene extract (TLE) proved effective in reducing LPS-induced NF-kB activity in vitro by blocking IkBa phosphorylation and p65 nuclear translocation, it exacerbated pathology in the DSS-induced injury model of colitis 24 . This deleterious effect correlated with a strong increase in colonic NF-kB (EGFP) activity in NF-kB EGFP mice, likely promoting expression of inflammatory cytokines by intestinal immune cells. Although TLE and oxymatrine both blocked NF-kB activity in vitro, the differential effects on colitis (protective vs deleterious) may be related to the extent of NF-kB inhibition. To that end, it is worth nothing that though the use of a higher oxymatrine concentration in vitro resulted in an increased inhibition of LPS-induced p65 nuclear translocation, this higher concentration was also associated with cellular toxicity. This suggests then that it is possible that NF-kB cyto-protective effect remains in oxymatrine-treated mice at the levels used in our study.
Although oxymatrine is considered to be safe and effective in treating Hepatitis B viral infections in China 36, 37 , additional investigation would be needed before this natural product could be considered for clinical use in the United States for treating intestinal inflammatory disorders. It would be important to demonstrate the efficacy of oxymatrine using various experimental models of chronic colitis such as the T-cell transfer or genetically engineered mice. In summary, our findings demonstrate that oxymatrine does possess anti-inflammatory effects in vitro and in vivo, acting at least in part through partial inhibition of NF-kB p65 nuclear translocation, which is independent of IkBa phosphorylation/degradation.
Methods
Animal ethics statement. All animal procedures were performed in accordance with UNC institutional animal care and use committee (IACUC)-approved protocols. Mice were housed in specific pathogen-free (SPF) facilities at the University of North Carolina at Chapel Hill.
Cell culture and treatment. The non-transformed rat small intestinal cell lines IEC-6 (ATCC CRL 1592, American Tissue Culture Collection (ATCC), Manassas, VA) and IEC-18 (ATCC CRL 1589) were cultured as previously described 38 . IEC cells were plated in 6-well plates (2.5 3 10 5 ) or 10 cm tissue culture plates (1 3 10 6 cells/mL) for experiments. Bone marrow-derived dendritic cells (BMDCs) were generated from wild-type C57BL/6 mice as previously described 39 and used at day-5 of culture for experiments. BMDCs were plated at a density of 1 3 10 6 cells/mL in 6-well plates. All cells were washed with serum-free media and serum-starved for 2 hr prior to incubation with oxymatrine (98% purity, Narula Research, Chapel Hill, NC). Oxymatrine was reconstituted in saline and added to media for 1 hr prior to LPS stimulation. LPS (Escherichia coli serotype O111:B4, Sigma-Aldrich, St. Louis, MO) was used at various concentrations to stimulate IECs and BMDCs.
NF-kB luciferase reporter assay. IEC-18 cells were infected for 16 h with an adenoviral vector encoding an NF-kB-luciferase reporter gene (Ad5kB-LUC) as previously described 40 . Cells were pretreated with various concentrations of oxymatrine for 1 h, followed by stimulation with LPS (5 mg/mL) for 8 h. Cell extracts were prepared using luciferase cell lysis buffer (PharMingen, San Digeo, CA). Luciferase assays were performed using an LMax luminometer microplate reader (Molecular Devices, Sunnyvale, CA), and results were normalized for extract protein concentrations measured with the Bio-Rad protein assay kit (Bio-Rad, Hercules, CA) as previously described 41 .
NF-kB immunofluorescence and Ki-67 immunohistochemistry. IEC-6 cells were pretreated with oxymatrine (4 mg/mL) for 1 hr and stimulated with LPS (5 mg/mL) for 30 min or 1 hr, cells were fixed and permeabilized using 100% ice-cold methanol for 10 min at 4uC. Immunofluorescent staining using p65 antibody (Millipore, anti-NF-kB CT, Billerica, MA) was performed as previously described 38 . Nuclear p65 aggregation was estimated by counting 3 random fields of view per slide utilizing an Olympus IX70 inverted epifluorescent microscope and data were reported as percentage of nuclear p65 positive cells.
Immunohistochemistry (IHC) was performed using tissue sections deparaffinized in xylene and rehydrated using a series of graded alcohol washes. Sections were probed using a Ki-67 monoclonal antibody (Dako, Carpinteria, CA) and biotinylated secondary antibody (Vector Laboratories, Burlingame, CA) as previously described 42 .
Western blot analysis. Proteins were extracted with RIPA buffer and quantified using Bio-Rad protein assay (Bio-Rad). Proteins (20 mg/sample) were separated by SDS-PAGE and transferred to nitrocellulose membranes (Hybond-C Extra Amersham Biosciences, Piscataway, NJ). Antibodies to phospho-IkBa (Cell Signaling Technology, Danvers, MA), phospho-p38MAPK and total p38MAPK (Cell Signaling) were diluted 15500 in 5% bovine serum albumin/TBS-tween and antibodies to total IkBa (Cell Signaling) 151000 and b-Actin (Santa Cruz Biotechnology, La Jolla, CA) 1510,000 in 5% milk/TBS-tween. Immunoreactive proteins were detected using the enhanced chemiluminescence light (ECL) detecting kit (Amersham, GE Healthcare Biosciences, Pittsburgh, PA) as previously described 38 . Densitometric values of immunoblot signals were obtained from 3 separate experiments using Adobe Photoshop.
Chromatin immunoprecipitation assay. Chromatin immunoprecipitations were performed as previously described 39, 43 . Briefly, IEC-18 cells were stimulated with LPS (5 mg/mL) alone or with oxymatrine (4 mg/mL) for 30 and 60 min, and ChIP assay performed using a ChIP assay kit (Upstate-Cell Signaling Solutions, Temecula, CA) according to the manufacturer's specifications. Immunoprecipitation was carried out overnight with 2 mg of p65 (c-20; Santa Cruz Biotechnology) or RNA polymerase II (c-21; Santa Cruz Biotechnology) antibodies. PCR was performed with total input DNA (5 ml) and immunoprecipitated DNA (5 ml) using cxcl2 promoter-specific primers: CXCL2 promoter forward, 59-CCTTCTTCCTGATGCAGGG-39; CXCL2 promoter reverse, 59-AGTCTGGGGCTGTGAGGTC-39. Thermal cycle conditions were as follows: one cycle of 5 min of 94uC, and 40 cycles of 94uC for 30 s, 60uC for 30 s, and 72uC for 30 s followed by an extension of 7 min at 72uC. The PCR products were subjected to electrophoresis on 2% agarose gels containing GelStar fluorescent dye (Cambrex BioScience, Rockland, ME). Fluorescence staining was captured using an Alpha Imager 2000 (Alpha Innotech, Santa Clara, CA).
Reverse transcriptase PCR and real time PCR. RNA was isolated using Trizol reagent (Invitrogen, Grand Island, NY) and manufacturer's recommended protocol. cDNA was prepared using reverse-transcriptase amplification kit (Invitrogen) and cytokine expression quantitated using real-time PCR (Applied Biosystems 7900HT Fast Real-Time PCR System) and SYBR Green PCR Master Mix kit (Qiagen, Valencia, CA). Primer sequences for rat Cxcl-2, murine TNFa, IL-6, IL-1b and GAPDH primers were used as previously described 24 . Sequences for rat TNFa 44 , GAPDH 45 , IL-6 and IL-1b were also previously described 46 .
DSS colitis. 8-12 week-old conventionally raised wild-type C57BL/6 mice or NF-kB EGFP mice (for NF-kB transcriptional studies) were exposed to 3% DSS (TdB Consultancy, Uppsala, Sweden) in drinking water as previously described 47 . Oxymatrine and saline solutions were prepared daily, and sterilized using a 0.22 mm filter (Fisher Scientific, Pittsburg, PA) prior to intraperitoneal injection (i.p). Oxymatrine dosage (50 and 200 mg/kg) were selected based on previous in vivo studies [8] [9] [10] 12, 14 . Mice were injected with oxymatrine 2 days prior to exposure to DSS. Mice were monitored daily for weight loss as well as signs of rectal bleeding and diarrhea. At d 9 of DSS administration, mice were sacrificed, sections were taken from the distal, proximal colon and cecum for histological assessment. EGFP expression was imaged as described previously 24 . Mice were sacrificed at the end of DSS-exposure according to our IACUC-approved protocol and colons excised. Tissues were prepared for swiss-roll analysis as previously described 47 . Analysis of histopathology was determined using the scoring system developed by Cooper 48 and Dieleman 49 and modified by Williams 50 using a 0 to 40 scale as previously described 47 .
Statistics. Data are represented as means 6 SEM. Statistics were calculated using GraphPad Prism 5.0d software, utilizing non-parametric 2-tailed t tests, One-way ANOVA or Mann-Whitney analysis and considered significant if p values were ,0.05.
